Plasvacc
24/7 HELP HOTLINE WITHIN AUSTRALIA 1800 752 762
  • Home
  • Products
    • Products overview
    • Equiplas
    • Equiplas-R
    • Equiplas-E
    • Caniplas
    • Caniplas E
    • CaniPRBC
    • Camelplas
    • Diagnostic Kits
  • How to buy
  • Technology
    • Plasma Therapy
    • Collection process
    • Thawing instructions
    • Product usage
    • Storage
  • Research
    • Scientific papers
    • White papers
    • Background papers
  • About
    • Company overview
    • Animal ethics
    • Plasvacc team
    • Regional commitment
  • Blog
  • Contact

Blog

Home» Blog

Plasvacc Expands to UK, Acquiring Veterinary Immunogenics

Posted on July 27, 2022 by Tamara Maudsley in Plasvacc News

PENRITH, UNITED KINGDOM — Plasvacc UK Ltd. is pleased to announce its entry into the United Kingdom through its acquisition of Veterinary Immunogenics Inc. Effective immediately, Plasvacc will undertake the day-to-day management of Veterinary Immunogenics under the oversight of site manager Fergus Macarthur. Incorporated in 1992, Veterinary Immunogenics has been producing and supplying hyperimmunised equine […]

View Post

Why Caniplas Should Be in Every Vets’ Freezer

Posted on July 7, 2022 by Tamara Maudsley in Canine

The process of plasmapheresis has been a staple of modern medicine for nearly 60 years, enabling countless therapies across a wide variety of care disciplines. And while its introduction into veterinary standards of care took several more decades, the process was originally successfully proven all the way back in 1916 with a canine patient. Today, […]

View Post

Ensuring Optimal Outcomes For Foals Faced With Rhodococcus Equi

Posted on June 8, 2022 by Tamara Maudsley in Equine

What is Rhodococcus equi? A bacterium found in soil worldwide, Rhodococcus equi (R. equi) is a common cause of bronchopneumonia in foals between 3 weeks and 5 months of age. While the survival rate of R equi pneumonia is upwards of 70% with appropriate therapy, the case fatality rate without therapy is a staggering 80%. […]

View Post

How Our Plasma Purity and Safety Protocols Impact Your Patient Outcomes

Posted on May 27, 2022 by Tamara Maudsley in Product Science

While the efficacy of plasma treatments has been long proven, they’re still only as effective as they are safe. With the highest possible level of safety and efficacy serving as our primary goal for each and every one of our products here at Plasvacc, we take great pride in adhering to the most stringent quality […]

View Post

The Plasma Collection Process

Posted on April 11, 2022 by Tamara Maudsley in Product Science

Veterinarians and breeders depend on high-quality biological products to fight disease and save the lives of their patients. At Plasvacc Australia, we take pride in the procedures and methods we use to collect our hyperimmunised plasma because we know superior plasma products make for healthy animals and grateful practitioners. Our Equine, Canine and Camel plasma […]

View Post

Camelplas: A Closer Look

Posted on March 17, 2022 by Tamara Maudsley in Product Science

Think of camels and, odds are, your mind will drift to the far-off deserts of North Africa and the Middle East. You’d be forgiven, as the Camelus dromedarius or dromedary camel is thought to have originated in Arabia or Somalia. However, it is now believed that the largest wild dromedary camel population now resides right […]

View Post

Why 100% Traceable, Single-source Donor, Cell-free Plasma Matters

Posted on February 22, 2022 by Tamara Maudsley in Product Science

Here at Plasvacc, we’ve devoted decades to developing our donor management and collection processes in order to provide the safest, most effective licensed equine and canine plasma products possible. Plasvacc was started for the benefit of our very own animals, and it has been a tireless labour of love to create a product lineup that […]

View Post

Caniplas and Parvovirus

Posted on January 21, 2022 by Tamara Maudsley in Product Science

Since its discovery in the late 1970s, canine parvovirus has been one of the leading causes of death in dogs due to its highly resilient, contagious, and aggressive nature. The fatality rate for puppies and unvaccinated dogs can be as high as 90% if left untreated. Parvovirus is easily transmitted through direct and indirect contact, […]

View Post

Meet Our Donor Dogs!

Posted on December 19, 2021 by Tamara Maudsley in Canine

Ever wonder what it’s like to be a dog in the Plasvacc donor pack? Well, wonder no further as we take this opportunity to introduce you to three of our beloved donors and take a look at how these happy hounds spend their days. What Breeds Make up the Plasvacc Donor Pack? Comprised of greyhounds, […]

View Post

What is Failure of Passive Transfer in Foals? A Comprehensive Look

Posted on October 26, 2021 by Tamara Maudsley in Product Science
Plasvacc - What is Failure of Passive Transfer

Veterinary professionals working with horses know just how devastating Failure of Passive Transfer (FPT) in foals can be. A serious condition that places newborn foals at risk of developing life-threatening complications, FPT can occur in 10-20% of foals, which in Australia alone can account for nearly 3,000 foals in a given year. At Plasvacc, we’ve […]

View Post
  • 1
  • 2
FoalsBestStart.com
Want the best for your dog?
See more products

About us

Plasvacc manufactures and distributes high quality hyperimmunised blood plasma products used to supplement the immune response system in animals. Plasma therapy shortens the course of treatments, reduces hospitalisation periods and lessens the quantity of drugs required to treat a variety of medical conditions.

SIGN UP FOR OUR MAILING LIST





    Contact us

    • Telephone: +61 7 5463 7600
    • Technical Support: 1-800-PLASMA | 1-800-752762
    • plasmail@plasvacc.com
    • Contact Us
      • ✉
      • 
      • 
      • 
    • Products
      • Equiplas
      • Equiplas-R
      • Equiplas-E
      • Caniplas
      • Caniplas E
      • CaniPRBC
      • Camelplas
      • Diagnostic Kits
    • How to buy
      • Wholesalers
    • Company overview
      • Plasvacc team
      • Animal ethics
      • Regional commitment
    • Research
      • Scientific papers
      • Background papers
      • White papers
    • Technology
      • Plasma therapy
      • Collection process
      • Thawing Instructions
      • Product usage
      • Storage

    (c) 2012 Plasvacc | All Rights Reserved | privacy policy

    Manage Cookie Consent
    We use cookies to optimise our website and our service.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    Preferences
    {title} {title} {title}